MaxCyte, Inc.MXCTNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank69
3Y CAGR-11.9%
5Y CAGR+2.8%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-11.9%/yr
vs +27.5%/yr prior
5Y CAGR
+2.8%/yr
Recent deceleration
Acceleration
-39.4pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$26.80M-15.0%
2024$31.53M-13.7%
2023$36.55M-6.7%
2022$39.16M+29.5%
2021$30.25M+29.2%
2020$23.40M+22.4%
2019$19.12M+29.0%
2018$14.83M+18.3%
2017$12.53M+14.3%
2016$10.96M-